Lilly to Participate in Bernstein Strategic Decisions Conference

INDIANAPOLIS, May 22, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the 30th Annual Sanford C. Bernstein Strategic Decisions Conference on Wednesday, May 28, 2014. John C. Lechleiter, Ph.D., Lilly's chairman, president and chief executive officer, will participate in a fireside chat at 3:00 p.m. EDT.

A live audio webcast will be available on the Webcasts & Presentations section of Lilly's Investor website at http://investor.lilly.com/events.cfm. Subsequently, a replay of the fireside chat with Dr. Lechleiter will be available on this same website for approximately 90 days.

About Eli Lilly and Company

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels. F-LLY

Refer to:  

(317) 276-5795 – Mark Taylor (Media)


(317) 655-6874 – Philip Johnson (Investors)

 

Eli Lilly and Company logo

Logo - http://photos.prnewswire.com/prnh/20031219/LLYLOGO

SOURCE Eli Lilly and Company

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.